Does dosing frequency of anti-CD20 therapies blunt vaccine responses and increase COVID-19 susceptibility in patients with multiple sclerosis?

被引：0
|
作者：
Avasarala, Jagannadha [1 ]
机构：
[1] Univ Kentucky Med Ctr, Dept Neurol, 740 S Limestone, Lexington, KY 40536 USA
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2024年 / 90卷 / 12期
关键词：
Anti-CD20; drugs; B cell repopulation; CD19 cell counts; COVID; 19; susceptibility; dosing frequency; multiple sclerosis; vaccine response; DEPLETION;
D O I：
10.1111/bcp.16248
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：3094 / 3096
页数：3
相关论文
共 50 条
  • [41] Immune responses following COVID-19 infection in multiple sclerosis patients using immunomodulatory therapy
    Bilge, Nuray
    Can, Fatma Kesmez
    Yevgi, Recep
    ACTA NEUROLOGICA BELGICA, 2023, 123 (05) : 1885 - 1892
  • [42] Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic
    van Lierop, Zoe Y. G. J.
    Toorop, Alyssa A.
    van Ballegoij, Wouter J. C.
    Dubbelink, Tom B. G. Olde
    Strijbis, Eva M. M.
    de Jong, Brigit A.
    van Oosten, Bob W.
    Moraal, Bastiaan
    Teunissen, Charlotte E.
    Uitdehaag, Bernard M. J.
    Killestein, Joep
    Kempen, Zoe L. E. van
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (07) : 1121 - 1125
  • [43] Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles (vol 14, 1158487, 2023)
    Fong, Chloe C.
    Spencer, Julian
    Howlett-Prieto, Quentin
    Feng, Xuan
    Reder, Anthony T.
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [44] Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy
    Gadani, Sachin P.
    Reyes-Mantilla, Maria
    Jank, Larissa
    Harris, Samantha
    Douglas, Morgan
    Smith, Matthew D.
    Calabresi, Peter A.
    Mowry, Ellen M.
    Fitzgerald, Kathryn C.
    Bhargava, Pavan
    EBIOMEDICINE, 2021, 73
  • [45] Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
    Petereit, Hela-Felicitas
    Tumani, Hayrettin
    Zettl, Uwe K.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [46] Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
    Piquet, Amanda L.
    Corboy, John R.
    Vollmer, Timothy L.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [47] Effect of Disease-Modifying Therapies on COVID-19 Vaccination Efficacy in Multiple Sclerosis Patients: A Comprehensive Review
    Jamali, Elham
    Shapoori, Shima
    Farrokhi, Majid Reza
    Vakili, Sina
    Rostamzadeh, Davoud
    Iravanpour, Farideh
    Oliaee, Razieh Tavakoli
    Jafarinia, Morteza
    VIRAL IMMUNOLOGY, 2023, 36 (06) : 368 - 377
  • [48] Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases
    Moehn, Nora
    Konen, Franz E.
    Pul, Refik
    Kleinschnitz, Christoph
    Pruss, Harald
    Witte, Torsten
    Stangel, Martin
    Skripuletz, Thomas
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 12
  • [49] A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis
    Fox, Edward
    Lovett-Racke, Amy E.
    Gormley, Matthew
    Liu, Yue
    Petracca, Maria
    Cocozza, Sirio
    Shubin, Richard
    Wray, Sibyl
    Weiss, Michael S.
    Bosco, Jenna A.
    Power, Sean A.
    Mok, Koby
    Inglese, Matilde
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (03) : 420 - 429
  • [50] mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity-Does it matter?
    Tutuncu, Melih
    Demir, Serkan
    Arslan, Gokhan
    Dinc, Oykue
    Sen, Sedat
    Gunduz, Tuncay
    Uzunkopru, Cihat
    Gumus, Haluk
    Tutuncu, Mesude
    Akcin, Rueveyda
    Ozakbas, Serkan
    Koseoglu, Mesrure
    Bunul, Sena Destan
    Gezen, Ozan
    Tezer, Damla Cetinkaya
    Baba, Cavid
    Ozen, Pinar Acar
    Koc, Rabia
    Elverdi, Tugrul
    Uygunog, Ugur
    Kuertuencue, Murat
    Beckmann, Yesim
    Dogan, Ipek Guengor
    Turan, Omer Faruk
    Boz, Cavit
    Terzi, Murat
    Tuncer, Asli
    Saip, Sabahattin
    Karabudak, Rana
    Kocazeybek, Bekir
    Efendi, Husnu
    Bilge, Ugur
    Siva, Aksel
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 75
12345